FIELD: medicine.
SUBSTANCE: invention refers to gene engineering, molecular biology and medicine. What is presented is a set of cardiac aging biomarkers involving a number of polynucleotides, which are differentially expressed in cardiac tissues of aged individuals as compared to young ones, wherein the polynucleotides are specified in two or more genes involved in Wnt-signal transmission into the cardiac tissues, wherein the genes represent Dlgh1, Magi3, Akt1, Dab2, Rac1, Ctnnb1, Camk2d, Mapk1, Senp2, Smad3, Mark2, Ccnd1 and Pias4, as well as a respective composition and a method for analysing an agent or a regimen for their ability to delay the cardiac aging.
EFFECT: set of the cardiac aging biomarkers.
16 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TISSUE-SPECIFIC BIOMARKERS OF AGEING | 2010 |
|
RU2557313C2 |
METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA | 2014 |
|
RU2670148C2 |
SELECTION OF CANCER PATIENTS FOR INTRODUCTION OF WNT SIGNAL INHIBITORS BASED ON RNF43 MUTATION STATUS | 2013 |
|
RU2636000C2 |
WNT ANTAGONISTS AND METHODS OF TREATING AND TESTING | 2011 |
|
RU2593947C2 |
STIMULATION OF PATHWAY Wnt IN REPROGRAMMING SOMATIC CELLS | 2008 |
|
RU2492232C2 |
MARKERS ASSOCIATED WITH WNT INHIBITORS | 2014 |
|
RU2663701C2 |
NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR | 2002 |
|
RU2316591C2 |
AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
METHOD FOR TISSUE REGENERATION STIMULATION | 2007 |
|
RU2480213C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF OSTEOARTHRITIS | 2009 |
|
RU2619553C2 |
Authors
Dates
2015-09-10—Published
2010-11-09—Filed